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The anaesthetist has seen his role steadily expand and it is
hard to think of one medical specialty in which anaesthetists
are not involved at least to some extent.  We present a range of
papers which demonstrates the breadth of anaesthesia: from
its traditional realm in the operating theatre to critical care and
resuscitation onto chronic pain and obstetric analgesia.
Airway Management
Undoubtedly, one of the key skills of the anaesthetist is the
ability to secure an airway. The golden standard is still the
endotracheal tube, but this requires skill at intubation. For this
reason, other means of obtaining an airway without resorting
to intubation have been marketed. These include the Guedel
airway, the Airway Management DeviceTM, the Laryngeal
TubeTM, the CombitubeTM and the Laryngeal Mask Airway
(LMA). These devices can all be inserted blindly and are suitable
for use by medical and paramedical staff not skilled at
intubation.
The most successful of these appears to be the LMA, of which
there are two main versions. The Classic LMA has been in use
for more than 10 years, and is basically a tube which is placed
just above the glottis and held in place with an inflatable cuff
(Figure 1a). Although it permits gas exchange through the
trachea, it does not protect the airway from regurgitation, and
the cuff only allows a good seal with positive pressures of not
more than 20cmH
2
O. The ProSealTM was marketed to overcome
these deficiencies. This has a bigger cuff which is more wedge-
shaped, allowing a better seal and the ability to ventilate with
higher positive pressures.1  It also incorporates a separate drain
tube, situated at the tip of the mask,  allowing insertion of a
gastric tube and to vent gas or liquid from the upper
oesophagus.1,2 (Figure 1b)
The ProsealTM is inserted blindly, and its design does not
take into account variations in anatomy. In fact, insertion and
correct placement have been proven to be more difficult with
the ProSealTM than with the Classic LMA1,3, but easier than the
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Laryngeal TubeTM.4 Malposition may result in significant
leakages from around the cuff or from the drain tube. Even
worse, it may occlude the vocal cords, and result in improper
ventilation.
Nevertheless the ProSealTM is having an impact: it is has been
used with success in caesarean deliveries when intubation was
difficult or impossible5, and in laparascopic surgery as an
alternative to tracheal intubation, which for years has been the
recommended standard.6  The ProSealTM is not a panacea, but it
is a useful addition to the armamentarium necessary to obtain
a secure airway.
Delivery of anaesthetic using
closed-loop systems
Open-loop control systems have been in use in anaesthesia
for a number of years.  The most popular such system is the
target-controlled infusion system for the administration of
propofol in total intravenous anaesthesia.  This system makes
intravenous anaesthesia simpler to perform by using a variety
of pharmacokinetic models and equations to produce a
predicted blood concentration.  It remains up to the anaesthetist
to select the appropriate blood concentration (the target) for
each patient.
Figure 1a: The Classic LMA and b) the Proseal LMA in
position. Note how the tip of the cuff in both variants should
be at the oesophagus.The cuff of the Proseal is also bigger
and more wedged shape, which should seal better the larynx.
a - airway tube
c - cuff
d - drain tube
e - epiglottis
o - oesophagus
p - port for inflation of cuf
t - trachea
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Closed-loop systems go one better by introducing an input
signal which is continuously compared to a target.  Any
difference between the target and the actual value is used to
alter the infusion of a drug so as to bring the patient’s value
closer to the required target.7  Simple systems exist for precise
control of blood pressure and neuromuscular blockade (using
infusions of nitroprusside and muscle relaxant respectively).
Absolam8 was the first to study a closed-loop system that actually
correlates depth of anaesthesia with the dose of anaesthetic
administered.  Depth of anaesthesia is measured with a
Bispectral-IndexTM System (a method of processing EEG into a
numerical score from 1 to 100 with a score less than 70 indicating
lack of awareness and a score less than 40 indicating excessive
depth of anaesthesia).  This feeds into the processor which is
linked to a propofol target-controlled infusion.  The system was
able to control anaesthesia adequately in twenty patients
undergoing body surface surgery.
Closed-loop systems have the potential for more precise
matching of anaesthesia to patient need thus reducing the risk
of underdosing (with the potential for awareness) and
overdosing (with problems of side-effects and prolonged
recovery).  Closed-loop systems may become one way in which
anaesthesia is administered in the future.
The anaesthetic management
of hypertensive patients
Hypertension is very common in practically all populations,
and it is hence inevitable that anaesthetists will frequently
encounter hypertensive patients, who may or may not be
controlled. Previous studies in the 1970s have shown that
hypertensive patients have a more vigorous response to noxious
stimuli.9 However, no large randomised controlled trial has ever
been performed that attempts to establish the relative risk of
patients with high blood pressure.
Howell, Sear and Foëx10 have reviewed data collected over
the past 30 years, and have concluded that moderate
hypertension alone does confer a small risk, but this was judged
to be clinically insignificant. They argue that the increased
afterload on the myocardium may be offset by a number of
measures, including peri-operative beta-blockers and thoracic
epidurals. As for severe hypertension, it is the presence of
hypertensive-related organ damage which increases
perioperative cardiac risk. The authors stress that surgery in a
hypertensive patient should not be postponed purely on the
basis of blood pressure readings; if, however, there is evidence
of end-organ damage then the surgery should be postponed to
allow time for the optimisation of the damaged organ. Either
way, anaesthesia for the severely hypertensive patient requires
experienced anaesthetists, as it is more important but more
difficult to maintain haemodynamic stability than in the
normotensive population.
Needeless techniques for nerve localisation
Upper and lower limb blocks can be very useful alternatives
to general anaesthetics: some patients welcome the lack of a
recovery period and sick patients can have their surgery
performed with minimal systemic disturbance.  Blocking major
nerves always involves puncture of the skin with a needle and
attempted localization of the nerve using a nerve stimulator to
elicit a muscle contraction; the contraction is strongest when
the needle is closest to the nerve.  Anatomical landmarks are
fairly reliable at directing the needle to the nerve but interpatient
variability means that several passes of the needle may be
necessary before the nerve is localized.  Multiple passes make
the procedure more painful and increase the risk of
complications such as major vessel damage and haematoma
formation.
Urmey et al11 describe the trial of a percutaneous (as opposed
to transcutaneous) technique for nerve localization.  A sheathed
electrode indents but does not puncture the skin and directs
the current to an area immediately below the indented skin.
When the nerve is localized the needle is passed through the
sheathed electrode and nerve localization is continued in the
usual way.  The investigators were able to demonstrate the
success of the technique and the reduction in the number of
passes required to localize a major nerve.  A subsequent paper
by another team shows that it is possible to accurately localize
smaller peripheral branches to increase the success rates of
nerve blockade, without increasing patient discomfort.12
Percutaneous nerve localization could soon become the
preferred method of performing regional anaesthesia.
Obstetric anaesthesia
A major advance in obstetric anaesthesia has been the
widespread increase in the use of epidural infusions for obstetric
analgesia, with epidural analgesia being used in 22% of births
in the United States in 1981 compared to 66% in 1997.13 In the
National Sentinel Caesarean Section Audit Report published in
2001, the epidural rate of UK hospitals was 24.5%.14
With epidural analgesia, a solution of local anaesthetic such
as bupivicaine or ropivicaine with or without opiates is infused
through a fine bore catheter into the epidural space, marked by
the ligamentum flavum posteriorly and the dural membrane
anteriorly.
The increase in the use of epidural analgesia has been
attributed to a number of factors. It is superior with regards to
pain relief when compared to pethidine or EntonoxTM. It allows
easy conversion to an emergency caesarean section under
neuroaxial blockade, which has been shown to reduce both foetal
and maternal complications. In a study by Sharma et al15,
whereby epidural analgesia was compared with intravenous
pethidine, pain relief was superior with epidural analgesia, with
95% of women who received epidural analgesia rating their
satisfaction as excellent or good compared with 69% of women
who received intravenous pethidine analgesia. Neonatal
outcome was better in mother with epidural analgesia, with
Apgar score being higher at 1 minute, and with less need for
rescue treatment for neonatal depression.
It has been claimed that the superior analgesia offered by
epidurals comes at the expense of a higher rate of instrumental
and Caesarean deliveries.16 However studies supporting this
claim tended to use high concentrations of local anaesthetic in
the epidural mixture, which caused a motor blockade that might
have prevented the parturient from pushing effectively. The
modern trend is to use very dilute local anaesthetics,
supplemented with opiates (which have no motor blocking
effects) that tend to block the sensory fibres only, sparing motor
fibres. The COMET trial (Comparative Obstetric Mobile
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Epidural Trial)17 established that the incidence of vaginal
deliveries increases when low-dose epidural analgesia is used,
without any loss of adequacy in analgesia.
Opiates for chronic non-malignant pain
Pain is the commonest symptom that causes patients to seek
medical advice. Pain is described as persistent when it has been
present for about 3 months. Common examples of persistent
pain are low back pain, osteoarthritis and postherpetic
neuralgia.  Persistent pain is a very common problem but it is
more difficult to treat than acute pain as while acute pain is
often a straightforward consequence of tissue damage,
persistent pain is conditioned by psychological, behavioural and
social aspects.  The relationship between actual damage and
intensity of chronic pain is much less clear.
The use of strong opioids in cancer pain has become
accepted practice. Their use for non-cancer pain has been less
enthusiastic18, this despite a growing body of opinion that
suggests that in a sub-group of patients with persistent non-
cancer pain, strong opioids can provide analgesia and improve
quality of life, without rapidly escalating doses or problem drug
use.  The Pain Society has issued a consensus statement19 that
attempts to provide guidelines to practitioners involved in the
care of such patients for the safe and rational use of opioids in
the setting of persistent non-cancer pain.  The main areas
addressed are:
1. The importance of proper patient selection
2. Care to the prevention and treatment of opioid side-effects
3. Putting the risk of tolerance and addiction into perspective:
patients established on a fixed dose of opiate do not seem
to develop tolerance, while addiction is rare occurrence.
4. The importance of careful follow-up with emphasis on the
fact that persistent non-cancer pain needs a
multidisciplinary approach and that one treatment modality
alone is unlikely to be enough.
5. Patients who do not derive benefit should have their opioid
discontinued.
These recommendations should form the basis for
development of more detailed local policies and guidelines.
Activated drotrecogin alfa in sepsis
The PROWESS trial established that recombinant activated
protein C (drotrecogin alfa) was an effective treatment for severe
sepsis with reductions in mortality and morbidity.20 Drotrecogin
alfa was the first pharmacological treatment for sepsis to show
benefit in a randomised controlled trial.  This paper21 looks at
the long-term outcome of survivors from the trial.  Older
observational studies suggested that sepsis survivors continued
to suffer increased mortality even after their episode of sepsis
had resolved.
In a blinded and independent fashion, Angus and
colleagues21 assessed long-term survival in subjects from
PROWESS. Although PROWESS enrolled patients from 1998
to 2000, the long-term follow-up study could not commence
until 2001 in order to guarantee that sufficient numbers of
patients had the potential to have lived an additional 2.5 years.
Strikingly, although 1220 persons survived to day 28 in
PROWESS, only 93 individuals were lost to follow-up.  In other
words, more than 90% of patients from many different nations
were identified.
The potential follow-up times ranged from 15 to 45 months
and the median available follow-up time was 43 months. In the
Kaplan-Meier survival curves for the entire cohort, the
difference noted at day 28 persisted out to 2.5 years. These
results are important for two reasons. First, they show that after
day 28, there was not some sudden increase in mortality in the
drotrecogin alfa (activated) arm that negated the initial
treatment benefit. Second, they highlight that drotrecogin alfa
(activated) offers an extended survival advantage and reinforces
the conclusion that clinicians are not simply delaying the
inevitable. The median survival in the placebo arm eventually
measured 846 days compared with 1113 days in the active
treatment group (an increase of 32% ).
Hormone replacement in organ donors
Organ transplantation has resulted in dramatic
improvements in the quality of life of patients who would have
otherwise relentlessly deteriorated.  However the major obstacle
in all transplantation programmes has been the availability of
organ donors.   The number of donors has reached a plateau in
most countries and there are no signs yet that this situation is
set to improve.  It is therefore imperative that patients who do
get to the organ donation stage have their organs maintained in
the best possible condition in order that the maximum number
of organs can then be harvested, thus gaining the greatest benefit
from an act of kindness.
In a retrospective analysis22 of all brain-stem dead donors
in the United States from January 1, 2000 to September 30,
2001, it was demonstrated that it is possible to improve yield of
organs by implementing so-called ‘hormone resuscitation’ on a
background of haemodynamic stability.  Hormone resuscitation
consists of a bolus of 15mg/kg methylprednisolone, an infusion
of vasopressin and an infusion of triiodothyronine or thyroxine.
Hyperglycaemia is treated with insulin.  The theory is that brain-
stem death leads to failure of the hypothalamo-pituitary axis
and that this results in severe metabolic derangement leading
to changes in cardiac muscle and other organs.  This protocol
resulted in a 22.5% increase in the number of organs recovered. 23
Hormone resuscitation is included in the standardized
management protocol of the United Network for Organ Sharing.
If hormone resuscitation can be shown to work in a prospective
trial, the number of organ donations will increase with
considerable benefit to many seriously ill patients.
Induced hypothermia following resuscitation
Resuscitation methods in the past focused on establishing
a circulation after cardiac arrest, but current research now aims
to improve neurological outcome following successful cardiac
resuscitation. Pharmacological methods, such as thiopentone,
corticosteroids and nimodipine, have not shown any benefit.
These target one pathway, however brain ischaemia and
subsequent reperfusion, activate a complex cascade of events
which is not regulated by just one pathway. A more global
approach needs to be used, and this may be achieved with mild
hypothermia soon after resuscitation.
Two large studies24,25 have shown that induced hypothermia
confers a good degree of neuroprotection from ischemia and
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reperfusion injury, with 51-55% of patients treated having good
neurological outcome compared to 26-39% in normothermic
patients. This was at the expense of more hyperglycaemia,
bleeding, pneumonia and sepsis.
Following these studies, the European Resuscitation Council
has advocated the use of mild hypothermia, (32-34oC) for 12-
24 hours, in comatose survivors of out-of-hospital cardiac arrest
caused by ventricular fibrillation.26  The Council is currently
keeping a registry of patients treated in this way in order to
document the clinical use of mild hypothermia and its outcome,
so as to issue appropriate guidelines. Inpatients and patients
with non-cardiac causes of arrest may also benefit, but the use
of induced hypothermia in such patients has not been
sufficiently studied.
Training with simulators
Anaesthesia is commonly looked upon by outsiders as being
95% boredom and 5% adrenaline.  This statement may be only
partially correct but it does emphasize the fact that in
anaesthesia it has become rare to encounter serious problems.
When things go wrong however, they do go wrong in a major
fashion and there is only a limited time-frame available in which
corrective measures can be applied with success.  The analogy
with flying an airplane is appropriate and indeed most flights
are a breeze but when things go wrong there is no time to look
up the manual!
Because anaesthetic mishaps are so uncommon it is difficult
for trainee anaesthetists to gain direct experience in their
handling.  Hence, as in pilot training the development of full
scale simulators which attempt to reproduce as faithfully as
possible changes in clinical scenarios has been a major step
forward.  Trainee anaesthetists can then be trained and assessed
in their handling of rare situations which can lead to a fatal
outcome e.g. anaphylaxis.27
The use of full-scale simulators in anaesthesia is increasingly
common over the past decade. Wong28 attempted to find
evidence that their use has led to better training and assessment.
Although it is tempting to assume that this is so, and students
consistently provide positive feedback, no studies could be found
that conclusively prove that use of simulators can eventually
lead to better patient outcomes. This does not mean that
simulation should be discarded; it merely reflects that these
systems are new and need to be evaluated and perfected.   We
believe that the usefulness and reliability of these tools will be
evident and an exciting future lies ahead for simulation exercises
in anaesthesia.
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